Stephen Keelan
Overview
Explore the profile of Stephen Keelan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AlGhanim K, Minkhorst K, Jaszkul K, Keelan S, Appleton S, DeLyzer T, et al.
Plast Surg (Oakv)
. 2025 Jan;
33(1):23-34.
PMID: 39876856
Breast implants were first introduced in the 1960s and have long been used for augmentation and reconstructive breast surgery. More recently, fat grafting for breast augmentation has gained popularity due...
2.
Dowling G, Keelan S, Cosgrove N, Daly G, Giblin K, Toomey S, et al.
Breast Cancer Res Treat
. 2024 Aug;
207(3):471-476.
PMID: 39090418
Purpose: Receptor and subtype discordance between primary breast tumours and metastases is a frequently reported phenomenon. The aim of this article is to review the current evidence on receptor discordance...
3.
Dowling G, Hehir C, Daly G, Hembrecht S, Keelan S, Giblin K, et al.
Breast
. 2024 May;
76:103749.
PMID: 38759577
Purpose: There are a wide variety of intraoperative techniques available in breast surgery to achieve low rates for positive margins of excision. The objective of this systematic review was to...
4.
Keelan S, Dowling G, Roche T, Hegarty A, Davey M, Dhannoon A, et al.
Br J Surg
. 2024 Mar;
111(3).
PMID: 38498075
Background: Electrosurgical devices are commonly used during mastectomy for simultaneous dissection and haemostasis, and can provide potential benefits regarding vessel and lymphatic ligation. The aim of this prospective RCT was...
5.
Dowling G, Daly G, Keelan S, Boland F, Toomey S, Hill A, et al.
Clin Breast Cancer
. 2023 Sep;
23(8):847-855.e2.
PMID: 37775347
Trastuzumab deruxtecan (T-DXd) is a novel antibody-drug-conjugate (ADC), primarily used in the treatment of HER2-positive breast cancer. This study aimed to conduct a systematic review to evaluate the efficacy and...
6.
Horan J, Reid C, Boland M, Daly G, Keelan S, Lloyd A, et al.
Ann Surg Oncol
. 2023 Jul;
30(10):6117-6124.
PMID: 37479843
Background: Breast cancer surveillance programmes ensure early identification of recurrence which maximises overall survival. Programmes include annual clinical examination and radiological assessment. There remains debate around the value of annual...
7.
Dowling G, Keelan S, Toomey S, Daly G, Hennessy B, Hill A
Front Oncol
. 2023 Feb;
13:1066007.
PMID: 36793602
Purpose: The development of human epidermal growth factor receptor 2 (HER2)-directed therapies has revolutionized the treatment of HER2-positive breast cancer. The aim of this article is to review the continually...
8.
Keelan S, Ola M, Charmsaz S, Cocchiglia S, Ottaviani D, Hickey S, et al.
Cancer Commun (Lond)
. 2023 Jan;
43(5):615-619.
PMID: 36670046
No abstract available.
9.
Keelan S, Boland M, Ryan E, Moran L, Davey M, Lloyd A, et al.
Br J Surg
. 2022 Dec;
110(3):324-332.
PMID: 36512473
Background: Sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in patients with breast cancer who are initially node-positive but convert to clinically/radiologically node-negative remains controversial. The primary aim was...
10.
Davey M, Keelan S, Lowery A, Kerin M
Clin Breast Cancer
. 2022 Oct;
22(8):e843-e849.
PMID: 36229335
Introduction: Invasive lobular carcinoma (ILCs) are typically endocrine responsive breast cancers which respond poorly to chemotherapy. The long-term survival advantage of prescribing chemotherapy in such cases remains unclear. To perform...